{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T05:32:37Z","timestamp":1780551157520,"version":"3.54.1"},"reference-count":27,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2012,3,27]],"date-time":"2012-03-27T00:00:00Z","timestamp":1332806400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J of Urology"],"published-print":{"date-parts":[[2012,7]]},"abstract":"<jats:p><jats:bold>Objectives:\u2003<\/jats:bold> To clarify the mechanism by which chronic bladder ischemia causes bladder functional changes, and to investigate the involvement of oxidative stress and pro\u2010inflammatory cytokines, and the effects of the phytotherapeutic drug, Eviprostat, on these biochemical marker levels and bladder function.<\/jats:p><jats:p><jats:bold>Methods:\u2003<\/jats:bold> Male Sprague\u2013Dawley rats aged 15\u2003weeks were divided into three groups. Arterial injury was experimentally induced by balloon endothelial injury of the iliac arteries, and a 2% cholesterol diet was given for 8\u2003weeks. Rats in the arterial\u2010injury group were given daily oral vehicle or Eviprostat, whereas sham\u2010operated animals on a regular diet (0.09% cholesterol) were given vehicle for the last 2\u2003weeks. Eight weeks after surgery, the levels of bladder pro\u2010inflammatory cytokines, as well as bladder and urinary oxidative\u2010stress markers, were determined. Cystometrograms were carried out without anesthesia or restraint.<\/jats:p><jats:p><jats:bold>Results:\u2003<\/jats:bold> Bladder and urinary oxidative\u2010stress markers, and bladder pro\u2010inflammatory cytokine levels were significantly increased in the arterial\u2010injury group, and Eviprostat markedly suppressed these increase. The cystometrograms showed that arterial injury decreased the intermicturition interval without affecting the micturition pressure. This decrease was reversed by Eviprostat treatment.<\/jats:p><jats:p><jats:bold>Conclusions:\u2003<\/jats:bold> Oxidative stress and pro\u2010inflammatory cytokines might be involved in the development of overactive bladder by atherosclerosis\u2010induced chronic bladder ischemia. Eviprostat might provide an attractive treatment option for individuals with bladder dysfunction due to chronic bladder ischemia because of its anti\u2010oxidant and anti\u2010inflammatory properties.<\/jats:p>","DOI":"10.1111\/j.1442-2042.2012.03000.x","type":"journal-article","created":{"date-parts":[[2012,3,29]],"date-time":"2012-03-29T12:28:43Z","timestamp":1333024123000},"page":"669-675","source":"Crossref","is-referenced-by-count":22,"title":["Suppression of bladder overactivity and oxidative stress by the phytotherapeutic agent, Eviprostat, in a rat model of atherosclerosis\u2010induced chronic bladder ischemia"],"prefix":"10.1111","volume":"19","author":[{"given":"Takahiro","family":"Matsui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiko","family":"Oka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomi","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsushi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Oyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Sagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Nomiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,3,27]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-009-0470-5"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0094-0143(05)70288-3"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2008.07587.x"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2006.06525.x"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2006.08.125"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2006.01.031"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2009.08717.x"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)68995-1"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/nau.21191"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/nau.21073"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02575222"},{"key":"e_1_2_8_13_2","first-page":"674","article-title":"Clinical study of Eviprostat for the treatment of benign prostatic hyperplasia","volume":"11","author":"Song Y","year":"2005","journal-title":"Zhonghua Nan Ke Xue"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2007.09.023"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2007.04.006"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2009.02.104"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/pros.21299"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2011.02.017"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.2909"},{"key":"e_1_2_8_20_2","first-page":"463","article-title":"Eviprostat, a drug for benign prostatic hyperplasia, ameliorates the urodynamic disturbance in rats with cystitis and with chronic urethral obstruction","volume":"28","author":"Sasaki Y","year":"2000","journal-title":"Jpn. Pharmacol. Ther."},{"issue":"1","key":"e_1_2_8_21_2","first-page":"15","article-title":"Cellular and molecular aspects of bladder hypertrophy","volume":"32","author":"Levin RM","year":"1997","journal-title":"Eur. Urol."},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2009.05.045"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/nau.10045"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(01)66307-9"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1520-6777(2000)19:1<43::AID-NAU6>3.0.CO;2-C"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2006.07.016"},{"key":"e_1_2_8_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/pros.20985"},{"key":"e_1_2_8_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2009.06.004"}],"container-title":["International Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1442-2042.2012.03000.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1442-2042.2012.03000.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T04:54:34Z","timestamp":1697345674000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1442-2042.2012.03000.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,27]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["10.1111\/j.1442-2042.2012.03000.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1442-2042.2012.03000.x","archive":["Portico"],"relation":{},"ISSN":["0919-8172","1442-2042"],"issn-type":[{"value":"0919-8172","type":"print"},{"value":"1442-2042","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,27]]}}}